UCB researchers at work. UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, the companies said, in a deal designed to expand the buyer’s presence in T-cell engager (TCE) antibodies ...
UCB is adding a big piece to its immunology pipeline with a multi-billion dollar deal to buy Candid Therapeutics, a clinical-stage biotech company developing therapies in a promising but competitive ...
UCB UCB0.73%increase; green up pointing triangle said it agreed to buy Candid Therapeutics for up to $2.2 billion, in a deal that seeks to bolster the Belgian pharmaceutical company’s pipeline of ...
UCB agreed to acquire Candid Therapeutics, a privately held clinical-stage biotechnology company focused on autoimmune and inflammatory diseases, for up to $2.2 billion, the companies said Sunday. The ...
Ken Song, Candid Therapeutics' CEO, previously sold radiopharma startup RayzeBio to BMS for $4.1bn. Belgian biotech UCB has made its second acquisition of the year, agreeing a front-loaded takeover of ...
A failed Palestinian suicide bomber delivered a speech to students at the University of California, Berkeley — earning raucous applause from the crowd during her video appearance for a “Palestinian ...
An elite college’s campus has seen two deaths in a 24-hour span this week, rocking the local community there. A 21-year-old student at the University of California, Berkeley, fell to his death near a ...
Authorities are investigating two deaths on the University of California, Berkeley campus that were discovered within a 24-hour span: a student who fell from a dorm building and a man found dead near ...
BERKELEY, Calif. (KGO) -- Two death investigations are underway on the University of California, Berkeley campus after two deceased men were found within a 24-hour period. The first incident occurred ...
BERKELEY, Calif. - The body of a man was discovered on UC Berkeley's campus Wednesday afternoon. Campus police say the person found does not appear to be affiliated with the university. What we know: ...
Belgian pharma company UCB (UCBJY) on Friday announced an agreement to acquire Neurona Therapeutics, a U.S.-based developer of cell therapies for neuronal diseases, for a total consideration of up to ...
After a recent streak of buyouts by some of Big Pharma's serial acquirers, Belgium's UCB is getting in on the action with a Friday acquisition potentially worth more than $1 billion. Building on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results